Hayek Kallen Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.39M | Sell |
8,765
-214
| -2% | -$103K | 1.33% | 24 |
|
|
2026
Q1 | $4.41M | Buy |
+8,979
| New | +$4.87M | 1.44% | 23 |
|
|
2025
Q4 | – | Sell |
-9,485
| Closed | -$4.6M | – | 173 |
|
|
2025
Q3 | $4.6M | Sell |
9,485
-542
| -5% | -$252K | 1.45% | 22 |
|
|
2025
Q2 | $4.07M | Sell |
10,027
-257
| -2% | -$107K | 1.38% | 22 |
|
|
2025
Q1 | $5.12M | Sell |
10,284
-265
| -3% | -$144K | 1.88% | 15 |
|
|
2024
Q4 | $5.49M | Sell |
10,549
-226
| -2% | -$124K | 1.99% | 13 |
|
|
2024
Q3 | $6.67M | Sell |
10,775
-195
| -2% | -$115K | 2.36% | 10 |
|
|
2024
Q2 | $6.07M | Sell |
10,970
-24
| -0.2% | -$13.7K | 2.26% | 10 |
|
|
2024
Q1 | $6.39M | Sell |
10,994
-85
| -0.8% | -$47.7K | 2.45% | 9 |
|
|
2023
Q4 | $5.88M | Sell |
11,079
-55
| -0.5% | -$26.6K | 2.46% | 8 |
|
|
2023
Q3 | $5.64M | Sell |
11,134
-174
| -2% | -$92.7K | 2.52% | 9 |
|
|
2023
Q2 | $5.9M | Buy |
11,308
+50
| +0.4% | +$27K | 2.51% | 10 |
|
|
2023
Q1 | $6.49M | Sell |
11,258
-1,070
| -9% | -$603K | 2.94% | 5 |
|
|
2022
Q4 | $6.79M | Sell |
12,328
-537
| -4% | -$285K | 3.13% | 7 |
|
|
2022
Q3 | $6.53M | Sell |
12,865
-59
| -0.5% | -$33K | 3.06% | 7 |
|
|
2022
Q2 | $7.02M | Sell |
12,924
-250
| -2% | -$138K | 3.06% | 7 |
|
|
2022
Q1 | $7.78M | Sell |
13,174
-379
| -3% | -$218K | 2.88% | 8 |
|
|
2021
Q4 | $9.04M | Sell |
13,553
-440
| -3% | -$275K | 3.22% | 4 |
|
|
2021
Q3 | $8M | Sell |
13,993
-1,043
| -7% | -$572K | 3.65% | 5 |
|
|
2021
Q2 | $7.58M | Sell |
15,036
-509
| -3% | -$240K | 3.19% | 5 |
|
|
2021
Q1 | $7.09M | Sell |
15,545
-179
| -1% | -$85.4K | 3.2% | 5 |
|
|
2020
Q4 | $7.32M | Sell |
15,724
-215
| -1% | -$101K | 3.54% | 4 |
|
|
2020
Q3 | $7.04M | Sell |
15,939
-609
| -4% | -$252K | 3.93% | 4 |
|
|
2020
Q2 | $6M | Buy |
16,548
+6
| +0% | +$2.01K | 3.39% | 5 |
|
|
2020
Q1 | $4.69M | Sell |
16,542
-607
| -4% | -$191K | 3.15% | 7 |
|
|
2019
Q4 | $5.57M | Sell |
17,149
-1,185
| -6% | -$359K | 3.22% | 7 |
|
|
2019
Q3 | $5.34M | Sell |
18,334
-744
| -4% | -$213K | 3.34% | 8 |
|
|
2019
Q2 | $5.6M | Sell |
19,078
-409
| -2% | -$113K | 3.55% | 7 |
|
|
2019
Q1 | $5.33M | Sell |
19,487
-2,094
| -10% | -$521K | 3.46% | 7 |
|
|
2018
Q4 | $4.83M | Sell |
21,581
-1,264
| -6% | -$297K | 3.46% | 7 |
|
|
2018
Q3 | $5.58M | Sell |
22,845
-374
| -2% | -$86K | 3.57% | 6 |
|
|
2018
Q2 | $4.81M | Sell |
23,219
-280
| -1% | -$59.4K | 3.32% | 7 |
|
|
2018
Q1 | $4.85M | Sell |
23,499
-1,029
| -4% | -$216K | 3.36% | 8 |
|
|
2017
Q4 | $4.66M | Sell |
24,528
-399
| -2% | -$76.4K | 3.06% | 10 |
|
|
2017
Q3 | $4.72M | Sell |
24,927
-614
| -2% | -$111K | 3.23% | 8 |
|
|
2017
Q2 | $4.46M | Sell |
25,541
-419
| -2% | -$70.4K | 3.01% | 9 |
|
|
2017
Q1 | $3.99M | Sell |
25,960
-288
| -1% | -$44K | 2.76% | 12 |
|
|
2016
Q4 | $3.7M | Sell |
26,248
-269
| -1% | -$39.7K | 2.7% | 14 |
|
|
2016
Q3 | $4.22M | Sell |
26,517
-6,964
| -21% | -$1.07M | 3.01% | 9 |
|
|
2016
Q2 | $4.95M | Sell |
33,481
-943
| -3% | -$139K | 3.55% | 6 |
|
|
2016
Q1 | $4.87M | Sell |
34,424
-659
| -2% | -$88.3K | 3.61% | 8 |
|
|
2015
Q4 | $4.98M | Sell |
35,083
-1,023
| -3% | -$136K | 3.81% | 4 |
|
|
2015
Q3 | $4.42M | Sell |
36,106
-1,329
| -4% | -$173K | 3.44% | 8 |
|
|
2015
Q2 | $4.86M | Buy |
37,435
+105
| +0.3% | +$13.7K | 3.63% | 7 |
|
|
2015
Q1 | $5.01M | Sell |
37,330
-859
| -2% | -$111K | 3.7% | 6 |
|
|
2014
Q4 | $4.79M | Sell |
38,189
-1,518
| -4% | -$185K | 3.53% | 8 |
|
|
2014
Q3 | $4.83M | Sell |
39,707
-2,515
| -6% | -$306K | 3.68% | 7 |
|
|
2014
Q2 | $4.98M | Sell |
42,222
-893
| -2% | -$105K | 3.77% | 7 |
|
|
2014
Q1 | $5.18M | Sell |
43,115
-2,743
| -6% | -$326K | 4.14% | 5 |
|
|
2013
Q4 | $5.11M | Sell |
45,858
-4,972
| -10% | -$494K | 3.97% | 3 |
|
|
2013
Q3 | $4.68M | Sell |
50,830
-2,970
| -6% | -$269K | 3.87% | 5 |
|
|
2013
Q2 | $4.55M | Buy |
+53,800
| New | +$4.48M | 3.85% | 7 |
|
Other funds holding TMO
Hayek Kallen Investment Management's TMO Position: Q2 2026 in Review
Hayek Kallen Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 2.4% in Q2 2026, selling an estimated $103K and leaving 8,765 shares worth $4.39M. The position accounts for 1.33% of the portfolio, ranked #24.
Hayek Kallen Investment Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.04M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Hayek Kallen Investment Management held 8,765 shares of Thermo Fisher Scientific worth $4.39M as of Q2 2026.
- Hayek Kallen Investment Management sold 214 Thermo Fisher Scientific shares in Q2 2026, an estimated $103K.
- Thermo Fisher Scientific made up 1.33% of Hayek Kallen Investment Management's portfolio in Q2 2026, its #24 holding.
- Hayek Kallen Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Hayek Kallen Investment Management's Thermo Fisher Scientific position peaked at $9.04M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Hayek Kallen Investment Management's 13F filing for Q2 2026, filed 17 Aug 2026.